Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNF – Get Free Report) shares shot up 37.5% during mid-day trading on Thursday . The stock traded as high as $0.19 and last traded at $0.17. 10,000 shares changed hands during trading, a decline of 53% from the average session volume of 21,500 shares. The stock had previously closed at $0.12.
Parnell Pharmaceuticals Price Performance
Parnell Pharmaceuticals Company Profile
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.
Featured Articles
- Five stocks we like better than Parnell Pharmaceuticals
- Why Are Stock Sectors Important to Successful Investing?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The Significance of Brokerage Rankings in Stock Selection
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is a Secondary Public Offering? What Investors Need to Know
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.